Department News

  • Research Excellence and Scholarship Highlighted at Annual Celebration Events
    The Larner College of Medicine's fourth annual "Celebrating Excellence in Research" series featured two days of presentations and recognition designed to highlight research performed by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
  • Shapiro Comments on Migraine Attitudes at American Headache Society Conference
    (JULY 31, 2019) Robert Shapiro, M.D., Ph.D., professor of neurological sciences, commented on findings he presented at the national American Headache Society meeting in an MDEdge/Neurology article.
  • Honors Night Celebrates Senior Medical Student and Faculty Achievements
    The Larner College of Medicine’s Class of 2019 Honors Night on May 13 was all about celebrating achievements. Medical students, leaders, faculty members, family and friends gathered for the event in UVM’s Davis Center to honor the recipients of individual student awards, faculty awards, a staff award, and a department award, as well as recognize the new student inductees for the Alpha Omega Alpha Honor Medical Society and Gold Humanism Honor Society.
  • Shapiro Comments on Migraines on
    (APRIL 11, 2019) An article published on SheKnows in the health and wellness section titled, "6 Misconceptions about Migraines That Need to Be Dispelled ASAP", featured comments from Robert Shapiro, M.D., UVM professor of neurology and founding president of the Alliance for Headache Disorders Advocacy.
  • Larner College of Medicine Faculty Inventions Recognized at Annual I2V Conference
    More than a dozen Larner College of Medicine faculty and scientists were recognized during the awards portion of the 14th annual Invention to Venture (I2V) conference April 5, 2019.
  • Class of 2021 Celebrates Teachers, Classmates at Foundations Awards Event
    The UVM Larner College of Medicine Class of 2021 participated in a Foundations Awards celebration January 24. The event, which marks the completion of the first level of the Vermont Integrated Curriculum, provides an opportunity for second-year medical students to join with faculty and staff and express their gratitude for the contributions of these Larner College of Medicine community members to their medical education journey.
  • Obesity Neural Systems Expert Grill Presents Stetson Lecture
    Harvey J. Grill, Ph.D., presented the Annual Stetson Lecture in Technological Advances in Medicine on Friday, September 14, 2018 in the UVM Davis Center’s Silver Maple Ballroom. Grill, a professor of behavioral neuroscience at the University of Pennsylvania and director of the Obesity Unit at the Institute of Diabetes, Obesity and Metabolism, discussed “Treating the Hyperphagia Driving Obesity: Neural Mechanisms of Feeding Inhibition.”
  • NIH Names Langevin Director of National Center for Complementary & Integrative Health
    Helene Langevin, M.D., C.M., a visiting professor of neurological sciences at the Larner College of Medicine at the University of Vermont and director of the Osher Center for Integrative Medicine at Brigham and Women's Hospital and Harvard Medical School, has been named director of the National Center for Complementary and Integrative Health.
  • UVM Larner College of Medicine Clinical Chairs’ Letter to the Community
    On July 18, 2018, UVM Larner College of Medicine clinical department chairs issued a letter to the community.
  • Celebrating Excellence in Research at the College – 2017 Achievements
    Vermont is among the top ten states in per capita research funding in the U.S., according to a State of Research at the College presentation delivered by Larner College of Medicine Senior Associate Dean for Research Gordon Jensen, M.D., Ph.D., at the Dean’s Excellence in Research Awards event held November 13, 2017. The last of three 2017 Celebrating Excellence in Research events held at the College on November 10 and 13, 2017, the awards ceremony recognized the accomplishments of faculty, residents, medical students, graduate students and postdoctoral trainees.
  • Neuroscience Graduate Students Host Brain Awareness Activities in Community
    The intricacies of neuroimaging tools, brain health and disease, and brain safety were the themes of educational presentations brought to greater Burlington, Vt.-area elementary, middle and high school students by doctoral candidates in the University of Vermont Neuroscience Graduate Program in honor of Brain Awareness Week in March.
  • Longden & Dabertrand’s Study on Capillaries’ Effect on Brain Blood Flow Gains National Coverage
    A new Nature Neuroscience study published by Assistant Professors of Pharmacology Thomas Longden, Ph.D., and Fabrice Dabertrand, Ph.D., determined that capillaries in the brain have a more active function that previously thought.
  • Teaching Academy Inducts New Members at Snow Season Education Retreat
    The newest members of the Teaching Academy at The Robert Larner, M.D. College of Medicine at The University of Vermont were inducted during a ceremony and dinner held January 5, 2017 that kicked off the Snow Season Education Retreat at the Sheraton Burlington Hotel and Conference Center.
  • Boyd Invested as Inaugural Hamill Green & Gold Professor of Neurological Sciences
    The University of Vermont Foundation hosted a special Investiture ceremony for an inaugural endowed position – the Robert W. Hamill, M.D. Green & Gold Professor in Neurological Sciences at the Robert Larner, M.D. College of Medicine – on December 6 in the Hoehl Gallery in the Health Science Research Facility. UVM President Tom Sullivan and Larner College of Medicine Dean Frederick Morin, M.D., presented James Boyd, M.D., associate professor of neurological sciences, as the first Hamill Green & Gold Professor at the event.
  • ALS Center at UVM Medical Center Mentioned in Vermont Business Magazine for Recent Grant
    The ALS Center at UVM Medical Center, led by Rup Tandan, M.D., F.R.C.P., professor of neurological sciences, recently received a $37,500 grant from the ALS Association of Northern New England to support patients and families struggling with Lou Gehrig’s disease, which was mentioned in Vermont Business Magazine.
  • Solomon Study on Multiple Sclerosis Misdiagnosis Supports Improved Education of Clinicians
    A number of common conditions are mistaken for multiple sclerosis (MS), a disabling central nervous system disease, say researchers at four academic medical centers across the U.S in a study published online today in the journal Neurology.
  • May's Study Finds Connection between Chronic Pain and Anxiety Disorders
    New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment. The study’s findings, published as an Article in Press in Biological Psychiatry, show that increased expression of PACAP – a peptide neurotransmitter the body releases in response to stress – is also increased in response to neuropathic pain and contributes to these symptoms.
  • Hehir Honored for Research and Clinical Commitment to Myasthenia Gravis Patients
    When University of Vermont neurologist Michael Hehir, M.D., treats patients with a relatively rare neuromuscular disorder called Myasthenia Gravis, he has to weigh the benefits of the medications he prescribes against their typical side effects.
  • Morielli Shares Goals as New Director of UVM Neuroscience Graduate Program
    To neuroscientist Anthony Morielli, Ph.D., the study of the brain opens a window to better understand the way the world works. “The brain is the one thing in the universe that can reflect back on itself,” says Morielli, a University of Vermont associate professor of pharmacology, who was recently named director of UVM’s Neuroscience Graduate Program.
  • UVM’s Gorman Co-Author of NIH-funded IRIS Study of Diabetes Drug as Stroke Prevention
    Results of the Insulin Resistance Intervention after Stroke (IRIS) trial presented February 17, 2016 at the International Stroke Conference 2016 in Los Angeles, Calif., and published in an Online First article in the New England Journal of Medicine, suggest a potential new method to prevent stroke and heart attack in high-risk patients who have already had one stroke or transient ischemic attack.